Healthcare -
Biotechnology - NASDAQ - US
$ 23.0
-0.611 %
$ 676 M
Market Cap
-4.44
P/E
ANAB - STOCK-BASED COMPENSATION
Stock-based Compensation ANAB - AnaptysBio, Inc.
34 M
LAST VALUE
11.56%
2 YEAR CAGR
22.36%
5 YEAR CAGR
70.92%
10 YEAR CAGR